These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16980217)

  • 1. Spondyloarthropathy: disease at the crossroads of immunity.
    FitzGerald O; McInnes I
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):949-67. PubMed ID: 16980217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate and adaptive immunity and the pathophysiology of psoriasis.
    Gaspari AA
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S67-80. PubMed ID: 16488332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of spondyloarthritis: autoimmune or autoinflammatory?
    Ambarus C; Yeremenko N; Tak PP; Baeten D
    Curr Opin Rheumatol; 2012 Jul; 24(4):351-8. PubMed ID: 22488076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathogenesis of psoriasis: recent insights on the role of adaptive and innate immunity.
    Bachelez H
    J Autoimmun; 2005; 25 Suppl():69-73. PubMed ID: 16263244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis.
    Van Beneden K; Coppieters K; Laroy W; De Keyser F; Hoffman IE; Van den Bosch F; Vander Cruyssen B; Drennan M; Jacques P; Rottiers P; Verbruggen G; Contreras R; Callewaert N; Elewaut D
    Ann Rheum Dis; 2009 Aug; 68(8):1360-5. PubMed ID: 18772190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding autoimmune disease: new targets for drug discovery.
    Balagué C; Kunkel SL; Godessart N
    Drug Discov Today; 2009 Oct; 14(19-20):926-34. PubMed ID: 19596080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment.
    Briot K; Gossec L; Kolta S; Dougados M; Roux C
    J Rheumatol; 2008 May; 35(5):855-61. PubMed ID: 18381782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc-receptors as regulators of immunity.
    Nimmerjahn F; Ravetch JV
    Adv Immunol; 2007; 96():179-204. PubMed ID: 17981207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune cell transcript modules reveal leukocyte heterogeneity in synovial biopsies of seronegative spondylarthropathy patients.
    Hallett RM; Chew T
    BMC Musculoskelet Disord; 2014 Dec; 15():446. PubMed ID: 25526985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct expression pattern of IFN-alpha and TNF-alpha in juvenile idiopathic arthritis synovial tissue.
    Gattorno M; Chicha L; Gregorio A; Ferlito F; Rossi F; Jarrossay D; Lanzavecchia A; Martini A; Manz MG
    Rheumatology (Oxford); 2007 Apr; 46(4):657-65. PubMed ID: 17085467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of innate and adaptive immunity on rejection and tolerance.
    Kim IK; Bedi DS; Denecke C; Ge X; Tullius SG
    Transplantation; 2008 Oct; 86(7):889-94. PubMed ID: 18852649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
    Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
    Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.
    Gisondi P; Cotena C; Tessari G; Girolomoni G
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):341-4. PubMed ID: 18005022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How the immune system achieves self-nonself discrimination during adaptive immunity.
    Jiang H; Chess L
    Adv Immunol; 2009; 102():95-133. PubMed ID: 19477320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should we consider tumor necrosis factor as the only target in spondyloarthritides?
    Ferraccioli G; Gremese E
    J Rheumatol Suppl; 2012 Jul; 89():94-6. PubMed ID: 22751604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa.
    Giamarellos-Bourboulis EJ; Antonopoulou A; Petropoulou C; Mouktaroudi M; Spyridaki E; Baziaka F; Pelekanou A; Giamarellou H; Stavrianeas NG
    Br J Dermatol; 2007 Jan; 156(1):51-6. PubMed ID: 17199566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new era for innate immunity.
    Montero Vega MT
    Allergol Immunopathol (Madr); 2008; 36(3):164-75. PubMed ID: 18680705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin.
    Bhattacharyya S; Mandal D; Sen GS; Pal S; Banerjee S; Lahiry L; Finke JH; Tannenbaum CS; Das T; Sa G
    Cancer Res; 2007 Jan; 67(1):362-70. PubMed ID: 17210719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
    Levesque MC; St Clair EW
    J Allergy Clin Immunol; 2008 Jan; 121(1):13-21; quiz 22-3. PubMed ID: 18206502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spondyloarthropathies: progress and challenges.
    Jacques P; Mielants H; De Vos M; Elewaut D
    Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):325-37. PubMed ID: 18455688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.